<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Head and Neck Cancer

Research    Head and Neck Cancer    Medical Oncology

CU Cancer Center Leaders Using a Molecule as a Weapon Against Cancer

After eight years of work by a pair of University of Colorado Cancer Center leaders on a new way to attack various cancers, the next stage in their quest to bring their therapy to patients is one of nine research endeavors receiving funding from the Anschutz Acceleration Initiative (AAI).


Author Mark Harden | Publish Date February 20, 2024
Full Story

Research    Head and Neck Cancer

New Study Aims to Better Treat Head and Neck Cancer in Dogs and Humans

A study is underway at Flint Animal Cancer Center in Fort Collins that has implications for human head and neck cancer. Funded by an administrative supplement for the Dog Oncology Grant Supplement (DOGS) Program issued by the National Cancer Institute (NCI) from the University of Colorado Cancer Center Head and Neck Cancer Specialized Programs of Research Excellence (SPORE), researchers speculate this study’s findings may improve outcomes for dogs and humans.  


Author Carie Behounek | Publish Date September 28, 2023
Full Story

Community    Head and Neck Cancer    Veteran and Military Health

PACT Act Allows Military Veterans to Access Benefits for Expanded List of Conditions Related to Exposures

When the PACT Act went into effect January 1, after being signed into law in August, many U.S. veterans were able to access benefits for an expanded list of health conditions presumed to be caused by exposure to toxic substances.


Author Rachel Sauer | Publish Date April 14, 2023
Full Story

Research    Head and Neck Cancer

Studying the Oral Cancer Immune Landscape in Dogs 

Squamous cell head and neck cancers — cancers that develop in the outer layers of tissue in the oral cavity, throat, larynx, and sinonasal cavity — are the sixth most prevalent cancer worldwide. The five-year survival rate for this type of cancer is 40% to 50%, with a worse prognosis for patients with advanced disease. 


Author Greg Glasgow | Publish Date March 21, 2023
Full Story

Research    Head and Neck Cancer    Clinical Trials

Innovative Technology Shows Great Promise Against Certain Head and Neck Cancers

Over the past decade, human papillomavirus (HPV) has increasingly been identified as a significant cause of certain head and neck cancers – for example, evidence suggests it causes 70% of oropharyngeal cancers in the United States.


Author Rachel Sauer | Publish Date March 03, 2023
Full Story

Community    Head and Neck Cancer   

Here’s What to Know About Martina Navratilova’s Double Cancer Diagnosis

On January 2, tennis great Martina Navratilova revealed that she has been diagnosed with two unrelated cancers: stage 1 throat cancer and early-stage breast cancer


Author Greg Glasgow | Publish Date January 04, 2023
Full Story

Research    Patient Care    Head and Neck Cancer    Clinical Trials    Immunotherapy

Clinical Trial Participation Helps Woman Diagnosed with Laryngeal Cancer Enjoy Every Day Without the Disease

Jane Hart is a lot of things: extremely proud mom of Shelby, daughter extraordinaire and apple of Jane’s eye. Dog mom to (deservedly spoiled) Maizy, Taco, Winnie, and Walter. Collector of Talavera pottery. Unabashed “Real Housewives of Salt Lake City” fan. A surprising 71, because she looks at least 10 years younger.

Cancer survivor – stage 4 laryngeal cancer that necessitated a tracheostomy and laryngectomy, that forced her to relearn how to breathe and talk.


Author Rachel Sauer | Publish Date December 16, 2022
Full Story

Press Releases    Head and Neck Cancer    Cancer   

CU Anschutz Researchers Find Less Invasive Treatment for Certain Head and Neck Cancers

A new study from researchers at the University of Colorado Anschutz Medical Campus has identified a less invasive way to treat a subset of head and neck cancers that could potentially change the standard of care for patients.


Author Kelsea Pieters | Publish Date November 28, 2022
Full Story

Head and Neck Cancer    Cancer    Oncology    Immunotherapy

Selective Nodal Radiation May Be a More Effective Approach in Cancer Treatment

A promising new study released by the University of Colorado Cancer Center suggests that recurrence of certain cancers can be significantly decreased by irradiating only a select set of lymph nodes near a tumor rather than all of them.


Author Laura Kelley | Publish Date November 16, 2022
Full Story

Research    Head and Neck Cancer    Clinical Trials

Research Leading to Clinical Trial Testing Two-Armed Approach to Treating Head and Neck Cancer

A crucial challenge in cancer research is figuring out how to make immunotherapies more effective, channeling, and selectively guiding the body’s own immune responses in targeting and killing tumors.


Author Rachel Sauer | Publish Date September 21, 2021
Full Story

Research    Honors    Head and Neck Cancer    Magazine    Funding

CU Cancer Center Receives Highly Competitive SPORE Grant for Head and Neck Cancer

Research and treatment of head and neck cancers at the University of Colorado Cancer Center reached a new level this month with a highly competitive Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI). The SPORE was approved by NCI Scientific Program leadership for FY2021 funding; the projected starting date is July 1.


Author Greg Glasgow | Publish Date June 07, 2021
Full Story

Research    Head and Neck Cancer

A New Method For Fighting ‘Cold’ Tumors

Not all cancerous tumors are created equal. Some tumors, known as “hot” tumors, show signs of inflammation, which means they are infiltrated with T cells working to fight the cancer. Those tumors are easier to treat, as immunotherapy drugs can then amp up the immune response.


Author Greg Glasgow | Publish Date April 22, 2021
Full Story

Research    Head and Neck Cancer

Inter-campus Collaboration Receives R01 Award to Study Salivary Gland Cancer

Two University of Colorado Cancer Center researchers have received a five-year R01 Award for $497,893 per year from the National Institutes of Health (NIH) to study a potential new drug treatment for salivary gland cancer. The award is part of an inter-campus collaboration between Antonio Jimeno, MD, PhD, co-leader of the Developmental Therapeutics Program, and Tin Tin Su, PhD, co-leader of the Molecular and Cellular Oncology Program.


Author Valerie Gleaton | Publish Date April 16, 2021
Full Story

Research    Head and Neck Cancer

Black Lives Also Matter in Cancer Care

Studies have long reported that Black cancer patients have poorer outcomes than their white counterparts. But two University of Colorado Cancer Center researchers decided to investigate the data further and figure out why. What they found was that the outcome disparity was caused not by biology, but simply by differences in access to health care.


Author Cancer Center | Publish Date October 01, 2020
Full Story

Research    Head and Neck Cancer    Cancer    Clinical Trials

CU Cancer Center Study Aims to Increase Access to Head and Neck Cancer Clinical Trials in Hispanic Population

Nearly two thousand people living in Colorado will be diagnosed with head and neck cancer (HNC) in 2020. Generally, a very aggressive disease, head and neck cancer require expert care that is not widely available in community cancer clinics. However, patients that are not well-represented in clinical studies, especially Hispanic patients, are less likely to get care from centers that specialize in the disease, such as the University of Colorado Cancer Center.


Author Cancer Center | Publish Date June 29, 2020
Full Story

Research    Faculty    Head and Neck Cancer

Improving Humanized Mouse Models for Head and Neck Cancer Research

If a new anti-cancer drug shows promise in a Petri dish, often the next step is to test the drug’s effect in mice. This system tends to work well with drugs that directly target cancer, but breaks down with immunotherapies. That’s because tumors from human cancer samples can only grow in mice with suppressed immune systems. Immunotherapies activate the immune system against cancer. And in a mouse model in which the immune system has been suppressed, there is no immune system to activate against cancer.


Author Garth Sundem | Publish Date August 23, 2018
Full Story

Research    Head and Neck Cancer

Grape Seed Extract Kills Head and Neck Cancer Cells, Leaves Healthy Cells Unharmed

Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million.


Author Garth Sundem | Publish Date January 26, 2012
Full Story

CU Cancer Center In the News

MHealthIntelligence

Leveraging RPM to Enable At-Home Care for High-Risk Cancer Patients

news outletMHealthIntelligence
Publish DateFebruary 05, 2024

Glen Peterson, DNP, ACNP, RN, from CU Cancer Center, discusses RPM & telehealth benefits for cancer patients on Healthcare Strategies podcast.

Full Story
9News

Sunday is World Cancer Day

news outlet9News
Publish DateFebruary 04, 2024

CU Anschutz oncologist and CU Cancer Center member Dr. Wells Messersmith shares insights: Colorado braces for over 29,000 cancer cases in the coming year.

Full Story
Cure Today

An Oncologist Explains How She Uses ctDNA in Gastric Cancer

news outletCure Today
Publish DateJanuary 24, 2024

CU Cancer Center member Sunnie Kim, MD, discussed how she uses ctDNA in treating patients with gastric or esophageal cancer.

Full Story
DocWire News

Toxicities and Duration of Treatment for Immunotherapy in Advanced Metastatic Hepatocellular Carcinoma

news outletDocWire News
Publish DateJanuary 23, 2024

CU Cancer Center member Christopher Lieu, MD, and Namrata Vijayvergia, MD, of the Fox Chase Cancer Center conclude their discussion with considerations for managing immunotherapy-related toxicities in patients with metastatic hepatocellular carcinoma (HCC), along with a review of the available evidence regarding the duration of immunotherapy treatment.

Full Story